HF/Transplantation

Top Story

Oral anticoagulation after low-risk TAVR safely reduces leaflet thrombosis

February 26, 2020
FDA News

Long-term ECMO system receives FDA clearance

February 25, 2020
The FDA recently cleared the Novalung extracorporeal membrane oxygenation system — the first to be cleared for more than 6 hours of use as extracorporeal life…
In the Journals

AI platform with wearable sensor patch may predict HF rehospitalizations

February 25, 2020
A wearable sensor predicted HF rehospitalizations with similar predictive accuracy to implantable devices, according to data from the LINK-HF study published in…
In the JournalsPerspective

Making tafamidis cost-effective for TTR amyloid cardiomyopathy may require 93% price reduction

February 19, 2020
Although tafamidis can provide substantial clinical benefit for patients with transthyretin amyloid cardiomyopathy, the drug exceeds cost-effectiveness thresholds at its…
More Headlines »